(19)
(11) EP 4 561 534 A2

(12)

(88) Date of publication A3:
14.03.2024

(43) Date of publication:
04.06.2025 Bulletin 2025/23

(21) Application number: 23850551.5

(22) Date of filing: 31.07.2023
(51) International Patent Classification (IPC): 
A61K 9/06(2006.01)
A61K 31/231(2006.01)
 A61K 31/728(2006.01)
A61P 19/02(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/1075; A61K 47/10; A61K 9/0024; A61L 27/54; A61L 27/52; A61L 2300/22; A61L 2300/236; A61L 2300/45; A61L 2400/06; A61L 2430/06; A61K 31/728; A61K 31/23
 
C-Sets:
  1. A61K 31/728, A61K 2300/00;
  2. A61K 31/23, A61K 2300/00;
(86) International application number:
PCT/TR2023/050755
(87) International publication number:
WO 2024/030103 (08.02.2024 Gazette 2024/06)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 31.07.2022 TR 202212108
03.10.2022 TR 202215122

(71) Applicant: Istanbul Medipol Universitesi
Istanbul (TR)

(72) Inventors:
  • ÜSTÜNDAG OKUR, Neslihan
    Istanbul (TR)
  • KARASULU, Hatice Yesim
    Istanbul (TR)
  • KESKIN, Ilknur
    Istanbul (TR)
  • SAHIN, Mustafa
    Istanbul (TR)
  • DEMIRALP, Bahtiyar
    Istanbul (TR)
  • ANTEPÜZÜMÜ BOLAT, Yüksel
    Istanbul (TR)
  • YOZGATLI, Vildan
    Istanbul (TR)

(74) Representative: Mutlu, Aydin 
Invokat Intellectual Property Services Ltd. Kartaltepe Mh. Yildiztepe Sk. No:6-Bakirköy
34145 Istanbul
34145 Istanbul (TR)

   


(54) FORMULATIONS COMPRISING HYALURONIC ACID AND CETYL MYRISTOLEATE AND THE USE OF THESE FORMULATIONS IN THE TREATMENT OF OSTEOARTHRITIS